Health
Animal data supports efficacy of baricitinib vs SARS-COV-2 – News-Medical.Net
The high burden of disease caused by the COVID-19 pandemic has led to much research on effective ways to mitigate the health, social, and economic impact of the spread of the infection. A recent study published on the preprint server bioRxiv* in September 202…
The high burden of disease caused by the COVID-19 pandemic has led to much research on effective ways to mitigate the health, social, and economic impact of the spread of the infection. A recent study published on the preprint server bioRxiv* in September 2020 reports on the characteristics of the drug baricitinib when used as monotherapy to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Inflammatory Responses in COVID-19
Severe COVID-19 is associated with high fever, non-…
-
Noosa News15 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
General13 hours agoQueensland mother accused of staging drowning death of four-year-old son committed to stand trial
-
General23 hours agoOutback Farm stars finish first barley harvest at Central Australian farm
-
Noosa News15 hours agoNon-compliance, human error led to $2m Noosa Council fraud